| In-silico screening and molecular dynamics simulation of drug bank experimental compounds against SARS-CoV-2 NA Alturki, MM Mashraqi, A Alzamami, YS Alghamdi, AA Alharthi, SA Asiri, ... Molecules 27 (14), 4391, 2022 | 31 | 2022 |
| A therapeutic journey of pyridine-based heterocyclic compounds as potent anticancer agents: a review (from 2017 to 2021) M Alrooqi, S Khan, FA Alhumaydhi, SA Asiri, M Alshamrani, MM Mashraqi, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022 | 29 | 2022 |
| Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and other coronaviruses: a genome-wide comparative annotation and analysis M Tarique, S Ahmad, A Malik, I Ahmad, M Saeed, A Almatroudi, T Qadah, ... Molecular and Cellular Biochemistry 476, 2203-2217, 2021 | 28 | 2021 |
| Hemi-Babim and fenoterol as potential inhibitors of MPro and papain-like protease against SARS-CoV-2: an in-silico study A Alzamami, NA Alturki, YS Alghamdi, S Ahmad, S Alshamrani, SA Asiri, ... Medicina 58 (4), 515, 2022 | 25 | 2022 |
| Unveiling the multitargeted potential of N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-L-cysteinylglycine (NSL-CG) against SARS CoV-2: A virtual screening and molecular dynamics … YS Alghamdi, MM Mashraqi, A Alzamami, NA Alturki, S Ahmad, ... Journal of Biomolecular Structure and Dynamics 41 (14), 6633-6642, 2023 | 23 | 2023 |
| Updated insights into the T cell-mediated immune response against SARS-CoV-2: a step towards efficient and reliable vaccines M Dhawan, AA Rabaan, MMA Fawarah, SA Almuthree, RA Alsubki, ... Vaccines 11 (1), 101, 2023 | 23 | 2023 |
| Promising Antimycobacterial Activities of Flavonoids against Mycobacterium sp. Drug Targets: A Comprehensive Review AA Rabaan, S Alhumaid, H Albayat, M Alsaeed, FS Alofi, MH Al-Howaidi, ... Molecules 27 (16), 5335, 2022 | 17 | 2022 |
| Development of a Candidate Multi-Epitope Subunit Vaccine against Klebsiella aerogenes: Subtractive Proteomics and Immuno-Informatics Approach A Umar, A Haque, YS Alghamdi, MM Mashraqi, A Rehman, F Shahid, ... Vaccines 9 (11), 1373, 2021 | 17 | 2021 |
| Molecular docking analysis of HER-2 inhibitor from the ZINC database as anticancer agents KHW Sait, M Mashraqi, AA Khogeer, O Alzahrani, NM Anfinan, HK Sait, ... Bioinformation 16 (11), 882, 2020 | 14 | 2020 |
| Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs MM Mashraqi, N Chaturvedi, Q Alam, S Alshamrani, MM Bahnass, ... Molecules 26 (3), 582, 2021 | 12 | 2021 |
| Mining therapeutic targets from the antibiotic-resistant Campylobacter coli and virtual screening of natural product inhibitors against its riboflavin synthase K Jalal, K Khan, A Hayat, D Ahmad, G Alotaibi, R Uddin, MM Mashraqi, ... Molecular Diversity 27 (2), 793-810, 2023 | 9 | 2023 |
| Therapeutic Target Identification and Inhibitor Screening against Riboflavin Synthase of Colorectal Cancer Associated Fusobacterium nucleatum NA Alturki, MM Mashraqi, K Jalal, K Khan, Z Basharat, A Alzamami Cancers 14 (24), 6260, 2022 | 8 | 2022 |
| Regulation of micro-RNA, epigenetic factor by natural products for the treatment of cancers: Mechanistic insight and translational association A Javaid, D Zahra, F Rashid, M Mashraqi, A Alzamami, M Khurshid, ... Saudi Journal of Biological Sciences 29 (6), 103255, 2022 | 8 | 2022 |
| Identification of Therapeutic Targets in an Emerging Gastrointestinal Pathogen Campylobacter ureolyticus and Possible Intervention through Natural Products K Khan, Z Basharat, K Jalal, MM Mashraqi, A Alzamami, S Alshamrani, ... Antibiotics 11 (5), 680, 2022 | 6 | 2022 |
| Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: An extensive MM\GBSA-based screening, and MD simulation study HH Almasoudi, MA Hakami, AY Alhazmi, M Makkawi, S Alasmari, ... Medical Oncology 40 (8), 218, 2023 | 5 | 2023 |
| Anti-tubercular activity evaluation of natural compounds by targeting Mycobacterium tuberculosis resuscitation promoting factor B inhibition: An in silico study AA Rabaan, M Garout, M Aljeldah, BR Al Shammari, A Alawfi, ... Molecular Diversity, 1-16, 2023 | 5 | 2023 |
| Prediction Model of Adverse Effects on Liver Functions of COVID‐19 ICU Patients A Mashraqi, H Halawani, T Alelyani, M Mashraqi, M Makkawi, S Alasmari, ... Journal of Healthcare Engineering 2022 (1), 4584965, 2022 | 5 | 2022 |
| Proteome based mapping and molecular docking revealed DnaA as a potential drug target against Shigella sonnei F Shahid, YS Alghamdi, M Mashraqi, M Khurshid, UA Ashfaq Saudi Journal of Biological Sciences 29 (2), 1147-1159, 2022 | 4 | 2022 |
| Identification of Potent Natural Resource Small Molecule Inhibitor to Control Vibrio cholera by Targeting Its Outer Membrane Protein U: An In Silico Approach A Rahaman, AA Almalki, MM Rafeeq, O Akhtar, F Anjum, MM Mashraqi, ... Molecules 26 (21), 6517, 2021 | 3 | 2021 |
| Prevalence, microbiological profile, and risk factors of surgical site infections in Saudi patients with colorectal cancer MG Aldriwesh, A Alnodley, N Almutairi, M Algarni, A Alqarni, B Albdah, ... Saudi Journal of Medicine & Medical Sciences 11 (3), 208-218, 2023 | 2 | 2023 |
